Home
MNOV
MNOV News

Latest Medicinova Inc (MNOV) News on July 26, 2024

MediciNova Chief Business Officer David H. Crean, Ph.D. Assumes Communications Role Overseeing Investor Engagement and Public Relations

GlobeNewswire

a month ago

MediciNova Chief Business Officer David H. Crean, Ph.D. Assumes Communications Role Overseeing Investor Engagement and Public Relations

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

2 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

2 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

2 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

2 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

2 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

2 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

2 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

2 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer

GlobeNewswire

2 months ago

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer

Zacks Small Cap Research

2 months ago

MNOV: Multiple Abstracts Presented at 92nd EAS Congress…

MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024

GlobeNewswire

2 months ago

MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024

MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions

GlobeNewswire

2 months ago

MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

GlobeNewswire

2 months ago

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

GlobeNewswire

2 months ago

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

Associated Press Finance

3 months ago

MediciNova: Q1 Earnings Snapshot

MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)

GlobeNewswire

3 months ago

MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)

MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago

Simply Wall St.

3 months ago

MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

GlobeNewswire

4 months ago

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

GlobeNewswire

4 months ago

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

GlobeNewswire

4 months ago

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

Companies Like MediciNova (NASDAQ:MNOV) Are In A Position To Invest In Growth

Simply Wall St.

4 months ago

Companies Like MediciNova (NASDAQ:MNOV) Are In A Position To Invest In Growth

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

GlobeNewswire

5 months ago

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

MNOV: Capital Efficient Model and Large Late-Stage Pipeline Makes MediciNova Stand Out Among Peers…

Zacks Small Cap Research

5 months ago

MNOV: Capital Efficient Model and Large Late-Stage Pipeline Makes MediciNova Stand Out Among Peers…

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

Simply Wall St.

6 months ago

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

Reuters

6 months ago

GLOBAL MARKETS-Stocks slip, yields rise after strong US labor data

Small-cap stocks could outperform in 2024, analyst explains

Yahoo Finance Video

6 months ago

Small-cap stocks could outperform in 2024, analyst explains

Riverview Bancorp (RVSB) Q3 Earnings and Revenues Miss Estimates

Zacks

6 months ago

Riverview Bancorp (RVSB) Q3 Earnings and Revenues Miss Estimates

Associated Press Finance

6 months ago

Riverview Bancorp: Fiscal Q3 Earnings Snapshot

Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024

GlobeNewswire

6 months ago

Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

GlobeNewswire

6 months ago

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

Seven Hills Realty Trust Fourth Quarter 2023 Conference Call Scheduled for Wednesday, February 21st

Business Wire

6 months ago

Seven Hills Realty Trust Fourth Quarter 2023 Conference Call Scheduled for Wednesday, February 21st

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Simply Wall St.

6 months ago

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully

Simply Wall St.

6 months ago

We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China

GlobeNewswire

6 months ago

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

PR Newswire

6 months ago

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock

Zacks

6 months ago

What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock

Business Wire

6 months ago

Intevac to Announce Fourth Quarter and Fiscal Year 2023 Results on February 5th

Vuzix Introduces Z100 Smart Glasses to Seamlessly Connect Workers with AI Optimization Tools

PR Newswire

7 months ago

Vuzix Introduces Z100 Smart Glasses to Seamlessly Connect Workers with AI Optimization Tools

Thomson Reuters StreetEvents

7 months ago

Q2 2024 AngioDynamics Inc Earnings Call

Business Wire

7 months ago

Rocky Brands, Inc. to Present at the 2024 ICR Conference

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire

7 months ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Intevac Announces Successful Qualification of TRIO™ System

Business Wire

7 months ago

Intevac Announces Successful Qualification of TRIO™ System

H World Group Limited Announces the Change of Officers

GlobeNewswire

7 months ago

H World Group Limited Announces the Change of Officers

High Tide to Open First Canna Cabana in Mississauga, Ontario

CNW Group

7 months ago

High Tide to Open First Canna Cabana in Mississauga, Ontario

4 Solid Stocks to Buy on Rise in Personal Income, Spending

Zacks

7 months ago

4 Solid Stocks to Buy on Rise in Personal Income, Spending

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

7 months ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology

GlobeNewswire

7 months ago

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology

Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program

PR Newswire

7 months ago

Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program

Investing in Interlink Electronics (NASDAQ:LINK) five years ago would have delivered you a 261% gain

Simply Wall St.

8 months ago

Investing in Interlink Electronics (NASDAQ:LINK) five years ago would have delivered you a 261% gain

Why Is Catalyst (CPRX) Up 16.2% Since Last Earnings Report?

Zacks

8 months ago

Why Is Catalyst (CPRX) Up 16.2% Since Last Earnings Report?

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

GlobeNewswire

8 months ago

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

Business Wire

8 months ago

Zepp Health Celebrates 10 Years of Innovation with a Purpose-Led Brand Refresh and Expanded Wellness Healthcare Solutions

inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia

Business Wire

8 months ago

inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia

Lesaka appoints fintech entrepreneur Ali Mazanderani as Chairman, Kuben Pillay as Lead Independent Director, and Chris Meyer to conclude tenure as Group CEO in February 2024

GlobeNewswire

8 months ago

Lesaka appoints fintech entrepreneur Ali Mazanderani as Chairman, Kuben Pillay as Lead Independent Director, and Chris Meyer to conclude tenure as Group CEO in February 2024

inTEST Corporation to Participate in the 12th Annual NYC Summit

Business Wire

8 months ago

inTEST Corporation to Participate in the 12th Annual NYC Summit

MNOV: Encouraging Phase 2 Glioblastoma Results Presented at SNO…

Zacks Small Cap Research

8 months ago

MNOV: Encouraging Phase 2 Glioblastoma Results Presented at SNO…

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable

Simply Wall St.

8 months ago

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

GlobeNewswire

8 months ago

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

Bancroft Fund Ltd. Declares Distribution of $0.32 Per Share

GlobeNewswire

8 months ago

Bancroft Fund Ltd. Declares Distribution of $0.32 Per Share

Owning 45% in HireQuest, Inc. (NASDAQ:HQI) means that insiders are heavily invested in the company's future

Simply Wall St.

8 months ago

Owning 45% in HireQuest, Inc. (NASDAQ:HQI) means that insiders are heavily invested in the company's future

a.k.a. Brands Holding Corp. (NYSE:AKA) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

a.k.a. Brands Holding Corp. (NYSE:AKA) Q3 2023 Earnings Call Transcript

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)

Simply Wall St.

8 months ago

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)

Associated Press Finance

9 months ago

MediciNova: Q3 Earnings Snapshot

Interlink Electronics Reports Third Quarter 2023 Results

PR Newswire

9 months ago

Interlink Electronics Reports Third Quarter 2023 Results

Associated Press Finance

9 months ago

Aemetis: Q3 Earnings Snapshot

Want $300 in Super-Safe Monthly Dividend Income? Invest $37,800 Into the Following 3 Ultra-High-Yield Stocks

Motley Fool

9 months ago

Want $300 in Super-Safe Monthly Dividend Income? Invest $37,800 Into the Following 3 Ultra-High-Yield Stocks

Share on Social Networks: